Tentative Program. Parkinsons & Huntington Disease. ***For available speaker slots*** conferenceseries.com.

Transcription

1 4 th World Congress on Tentative Program Parkinsons & Huntington Disease August 29-30, 2018 Zurich, Switzerland Interactive Sessions Keynote Lectures Plenary Lectures Workshops Exhibitors B2B Meetings ***For available speaker slots***

2 4th World Congress on Parkinsons & Huntington Disease August 29-30, 2018 Zurich, Switzerland Program at a Glance Confirm your speech slot: parkinson@neuroconferences.com Day 1 Reception/Registratio n Keynote/ Plenary Talks Time General Session Inaugural Address Keynote/Plenary Talk 1 Keynote/Plenary Talk 2 Keynote/Plenary Talk 3 Keynote Slots Available s/group Photo Coffee/Tea Break (Networking) Session 1 Session Parkinson Disease Epidemiology of Parkinsons Lunch Break Neuromuscular Disorders Huntington Disease Coffee/Tea Break (Networking) Wokshop/Symposium Speaker Slots Available Day 2 Time Session 1 Session Keynote Forum Keynote Forum Coffee/Tea Break (Networking) Risk Factors of Parkinson s disease Lunch Break Parkinson s disease: Diagnosis for Parkinson s Complications, Free Radicles and disease Aging in Parkinsons Insights and Therapeutics: Mitochondrial Dysfunction Parkinson s Disease Coffee/Tea Break (Networking) Managing life with Parkinso Speaker Slots Available Pathophysiology and Pharmacology Neurosurgery, Clinical Trials in Parkinsonism NOTE: Program Shedule is subject to change with final allotment of the speaker slots For more Details PS: parkinsoncongress@neuroconferences.com

3 Conference Highlights Parkinson Disease Epidemiology of Parkinsons Neuromuscular Disorders Huntington Disease Risk Factors of Parkinson s disease Pathophysiology and Pharmacology Diagnosis for Parkinson s disease Parkinson s disease: Complications Mitochondrial Dysfunction Insights and Therapeutics: Parkinson s Disease Managing life with Parkinson s Disease Neurosurgery Free Radicles and Aging in Parkinsons Novel Therapeutics Clinical Trials in Parkinsonism For detailed sessions, please visit: registration.php Submit your abstract online at: abstract-submission.php

4 Glimpses of Parkinsons Conferences 2017

5 BEST TOURIST ATTRACTIONS IN ZURICH, SWITZERLAND Grossmunster Lake zurich Mount Titils Old Town Bahnhofstrasse Zurich Opera House Zoo Zurich

6 Scientific Program 3 rd International Conference on Parkinson s Disease & Movement Disorders September 25-26, 2017 Chicago, USA Conference Series - America One Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA P: , F: Conference Series - UK Kemp House, 152 City Road, London EC1V 2NX Toll Free:

7 Registrations Day 1 September 25, 2017 Hall - Vienna conferenceseries.com Opening Ceremony Keynote Forum Introduction Title: Management of psychosis in Parkinson s disease Susan Scanland, Dementia Connection LLC, USA Networking & Refreshment Break Title: The impact of wearing off on quality of life in patients with Parkinson's disease Srinivas Avathvadi Venkatesan, DR.M.G.R.Medical University, India Title: Novel pharmaceutical interventions to relieve L-DOPA induced dyskinesia in Parkinson s disease Jayakumar Rajadas, Stanford University, USA Group Photo Sessions: Epidemiology of Parkinson Disease Neurocognitive Disorders Session Chair: Srinivas Avathvadi Venkatesan, DR.M.G.R.Medical University, India Session Introduction Title: Relationship between the stride length and cadence in patients with Parkinson s disease Míra Ambrus, University of A Coruna, Spain Lunch Break Title: Impact of vinpocetine on the therapeutic effectiveness of L-DOPA using rat model of Parkinson's disease Azza A Ali, Al-Azhar University, Egypt Special Session Title: Motor sensory stimulation (Modulation) in Parkinsonism Srinivas Avathvadi Venkatesan, DR.M.G.R.Medical University, India Sessions: Pathophysiology, Pharmacology Parkinson s Disease Complications Diagnosis for Parkinson Disease Session Chair: Rajendra D Badgaiyan, University of Richmond, USA Session Introduction Title: Somatosensory abnormalities in Parkinson s disease and evidence from functional neuroimaging Aimee J Nelson, McMaster University, Canada Networking & Refreshment Break Title : Discussing with your patients the importance of reclaiming posi-spective, uncovering your purpose and staying engaged John M Baumann, University of Louisville, USA Title: Novel insights and therapeutics for Parkinson s disease Harish C Pant, National Institutes of Health, USA Title: Imparment of synaptic activity through reduced CaMKII activity in Parkinson s disease model mice Kohji Fukunaga, Tohoku University, Japan Day 2 September 26, 2017 Page 7

8 Hall - Vienna Keynote Forum Introduction Title: Novel neuroimaging technique to study Parkinson s disease Rajendra D Badgaiyan, University of Richmond, USA Title: Complete communication of the potential medical and non-medical effects of parkinson s on newly diagnosed patients by neurologists and movement disorder specialists John M Baumann, University of Louisville, USA Networking & Refreshment Break Title: Nothobranchius furzeri: A new model organism of alpha-synucleinopathy Tyrone Genade, Northwestern College, USA Sessions: Managing life with Parkinson s Disease Novel Insights and Therapeutics for Parkinson s Disease Session Chair: Jayakumar Rajadas, Stanford University, USA Session Introduction Title: Reprogramming and programming of human hindbrain cells Jianfeng Lu, Tongji University, China Title: Improvement quality of life of people with Parkinson s disease by physical and psychosocial approach: Experience of Kaunas UAS/Kauno Kolegija project Viktorija Piscalkiene, Kaunas University of Applied Sciences, Lithuania Title: Synthetic steps towards reversible chalcogen-based sensing of essential neurodegenerative disease factors Tesla Yudhistira, Korea Advanced Institute of Science and Technology, Korea Lunch Break Title: If I knew then, what I know now the definitive guide for those who do not have a chronic illness John M Baumann, University of Louisville, USA Special Session Title: Novel disease-modifying drugs inhibiting alpha-synuclein aggregation in Parkinson s disease model mice Kohji Fukunaga, Tohoku University, Japan Poster Presentations Title: Olfactory hallucination in a super smeller P1 Weller A, Carribbean Medical University School of Medicine, USA Title: Modulatory effects of bisphenol A, caffeine, epigallocatechin-3-gallate and their P2 combinations against parkinsonism in rats Azza A Ali, Al-Azhar University, Egypt Title: Comparative study on the potential role of cocoa, epigallocatechin-3- gallate, coenzyme Q10 P3 and their combination against manganese-induced parkinsonian like syndrome in rats Azza A Ali, Al-Azhar University, Egypt Title: 9-tert-butyl-apomorphine (DTBA) as an effective soluble compound with antioxidant activity P4 for treatment of experimental Parkinsonism G Shilau, Belarussian State University, Belarus Networking & Refreshment Break Award Cermony Thanks Giving & Closing Ceremony Page 8